Direct percutaneous left ventricular access and port closure: Pre-clinical feasibility

Israel M. Barbash, Christina E. Saikus, Anthony Z. Faranesh, Kanishka Ratnayaka, Ozgur Kocaturk, Marcus Y. Chen, Jamie A. Bell, Renu Virmani, William H. Schenke, Michael S. Hansen, Michael C. Slack, Robert J. Lederman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


This study sought to evaluate feasibility of nonsurgical transthoracic catheter-based left ventricular (LV) access and closure. Implanting large devices, such as mitral or aortic valve prostheses, into the heart requires surgical exposure and repair. Reliable percutaneous direct transthoracic LV access and closure would allow new nonsurgical therapeutic procedures. Percutaneous direct LV access was performed in 19 swine using real-time magnetic resonance imaging (MRI) and an "active" MRI needle antenna to deliver an 18-F introducer sheath. The LV access ports were closed percutaneously using a commercial ventricular septal defect occluder and an "active" MRI delivery cable for enhanced visibility. We used "permissive pericardial tamponade" (temporary fluid instillation to separate the 2 pericardial layers) to avoid pericardial entrapment by the epicardial disk. Techniques were developed in 8 animals, and 11 more were followed up to 3 months by MRI and histopathology. Imaging guidance allowed 18-F sheath access and closure with appropriate positioning of the occluder inside the transmyocardial tunnel. Of the survival cohort, immediate hemostasis was achieved in 8 of 11 patients. Failure modes included pericardial entrapment by the epicardial occluder disk (n = 2) and a true-apex entry site that prevented hemostatic apposition of the endocardial disk (n = 1). Reactive pericardial effusion (192 ± 118 ml) accumulated 5 ± 1 days after the procedure, requiring 1-time drainage. At 3 months, LV function was preserved, and the device was endothelialized. Direct percutaneous LV access and closure is feasible using real-time MRI. A commercial occluder achieved hemostasis without evident deleterious effects on the LV. Having established the concept, further clinical development of this approach appears realistic.

Original languageEnglish
Pages (from-to)1318-1325
Number of pages8
JournalJACC: Cardiovascular Interventions
Issue number12
StatePublished - Dec 2011
Externally publishedYes


FundersFunder number
National Institutes of HealthZ01-HL006041-01, Z01-HL006040-01, Z01-HL006039-01, Z01-HL005062-08
National Heart, Lung, and Blood InstituteZIGHL006020
Division of Intramural Research, National Institute of Allergy and Infectious Diseases


    • hybrid surgical procedures
    • interventional magnetic resonance imaging
    • periventricular
    • transcatheter aortic valve replacement


    Dive into the research topics of 'Direct percutaneous left ventricular access and port closure: Pre-clinical feasibility'. Together they form a unique fingerprint.

    Cite this